![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
1. 438056-69-0
2. 3-morpholinone, 4-(4-aminophenyl)-
3. 4-(4-aminophenyl)-3-morpholinone
4. Mfcd08236742
5. H6n2py6wst
6. C10h12n2o2
7. N-(4-aminophenyl)-3-morpholinone
8. 4-(4-aminophenyl) Morpholin-3-one
9. 4-(3-oxo-4-morpholinyl)aniline
10. 4-(4-amino-phenyl)-morpholin-3-one
11. Unii-h6n2py6wst
12. Ec 610-147-8
13. 4-(3-oxomorpholino)aniline
14. Schembl76558
15. 4-(4-morpholin-3-onyl)aniline
16. Dtxsid90458314
17. Albb-036321
18. Bcp27186
19. Cs-b0473
20. 4-(4-aminophenyl)-morpholin-3-one
21. 4-(4-aminophenyl)morpholine-3-one
22. Bbl037032
23. Cl3546
24. Stl560142
25. Zinc20398316
26. 4-(3-oxo-morpholin-4-yl)phenylamine
27. 4-(4-amino-phenyl)-morpholine-3-one
28. Akos006284751
29. Ac-2721
30. Bcp9000132
31. He-0208
32. N-4-aminophenylmorpholin-3-one
33. Pb25032
34. Sy002674
35. Am20040476
36. 4-(4-aminophenyl)morpholin-3-one, Aldrichcpr
37. A15571
38. 056a690
39. 4-(4-aminophenyl-2,3,5,6-d4)morpholin-3-one
40. Q-102520
Molecular Weight | 192.21 g/mol |
---|---|
Molecular Formula | C10H12N2O2 |
XLogP3 | 0.3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 1 |
Exact Mass | 192.089877630 g/mol |
Monoisotopic Mass | 192.089877630 g/mol |
Topological Polar Surface Area | 55.6 Ų |
Heavy Atom Count | 14 |
Formal Charge | 0 |
Complexity | 212 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.